Aurisco PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Aurisco PharmaceuticalLtd has a total shareholder equity of CN¥1.9B and total debt of CN¥77.5M, which brings its debt-to-equity ratio to 4.1%. Its total assets and total liabilities are CN¥2.4B and CN¥497.9M respectively. Aurisco PharmaceuticalLtd's EBIT is CN¥244.3M making its interest coverage ratio -7.2. It has cash and short-term investments of CN¥521.0M.
Key information
4.1%
Debt to equity ratio
CN¥77.54m
Debt
Interest coverage ratio | -7.2x |
Cash | CN¥520.99m |
Equity | CN¥1.87b |
Total liabilities | CN¥497.87m |
Total assets | CN¥2.37b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 605116's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥423.0M).
Long Term Liabilities: 605116's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥74.9M).
Debt to Equity History and Analysis
Debt Level: 605116 has more cash than its total debt.
Reducing Debt: 605116's debt to equity ratio has increased from 0.7% to 4.1% over the past 5 years.
Debt Coverage: 605116's debt is well covered by operating cash flow (472.9%).
Interest Coverage: 605116 earns more interest than it pays, so coverage of interest payments is not a concern.